An observational study in Overweight and Obesity in Schoolchildren, sponsored by Isabelle Herter-Aeberli. Completed at 1 site in Switzerland. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-13.
Sponsored by Isabelle Herter-Aeberli · Observational
The aim of the present study is to assess the prevalence of overweight and obesity in 6 to 12 year old children in Switzerland. This data will be used to investigate trends in the development of overweight and obesity in Switzerland. In addition, a questionnaire will be used to assess data on physical activity, nutrition, health and socioeconomic background and waist circumference as well as skin fold thicknesses will be measured.
All children at the selected schools and in the defined age range are eligible.
Exclusion Criteria:
Prevalence of overweight and obesity
Based on weight and height measurements BMI z-scores will be calculated for the classification in the different weight status groups (underweight, normal weight, overweight, obese)
Time frame: 1 day of first visit
Waist circumference
Time frame: 1 day of first visit
body fat %
Based on the measurement of skinfold thicknesses at 4 sites body fat % will be calculated
Time frame: 1 day of first visit
Physical activity
Assessed using a questionnaire
Time frame: 1 day of first visit
Nutrition
Assessed using a questionnaire
Time frame: 1 day of first visit
General health
Assessed using a questionnaire
Time frame: 1 day of first visit
Socioeconomic background
Assessed using a questionnaire
Time frame: 1 day of first visit
Age
Assessed using a questionnaire
Time frame: 1 day of first visit
Gender
Assessed using a questionnaire
Time frame: 1 day of first visit
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Isabelle Herter-Aeberli